Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.20.4
Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Sep. 30, 2019 $ 555 $ 9,594,100 $ (12,440,142) $ (2,845,487)
Balance, shares at Sep. 30, 2019 5,547,643      
Sale of common stock, net of issuance costs $ 13 2,715,017 2,715,030
Sale of common stock, net of issuance costs. shares 128,313      
Issuance of common stock to settle related-party notes $ 1 199,999 200,000
Issuance of common stock to settle related-party notes, shares 8,526      
Net loss (2,469,054) (2,469,054)
Balance at Dec. 31, 2019 $ 569 12,509,116 (14,909,196) (2,399,511)
Balance, shares at Dec. 31, 2019 5,684,482      
Balance at Sep. 30, 2020 $ 1,472 39,723,702 (36,705,257) 3,019,917
Balance, shares at Sep. 30, 2020 14,724,105      
Warrant exercises $ 2 2
Warrant exercises, shares 23,863      
Net share settlement of warrants $ 243 (243)
Net share settlement of warrants, shares 2,427,761      
Share-based compensation 370,055 370,055
Net loss (5,877,240) (5,877,240)
Balance at Dec. 31, 2020 $ 1,717 $ 40,093,514 $ (42,582,497) $ (2,487,266)
Balance, shares at Dec. 31, 2020 17,175,729